170 related articles for article (PubMed ID: 29223018)
1. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
Thomson NC
Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
[TBL] [Abstract][Full Text] [Related]
2. Editorial overview: Respiratory: Pulmonary pharmacology - It is time for a breath of fresh air.
Cazzola M; Matera MG
Curr Opin Pharmacol; 2018 Jun; 40():iv-viii. PubMed ID: 29859765
[No Abstract] [Full Text] [Related]
3. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant pharmacological therapies for COPD.
Rahman I; MacNee W
Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant therapeutic advances in COPD.
Rahman I
Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
[TBL] [Abstract][Full Text] [Related]
7. Emerging pharmaceutical therapies for COPD.
Lakshmi SP; Reddy AT; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2017; 12():2141-2156. PubMed ID: 28790817
[TBL] [Abstract][Full Text] [Related]
8. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
9. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
10. Statins in the treatment of COPD and asthma-where do we stand?
So JY; Dhungana S; Beros JJ; Criner GJ
Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant therapies in COPD.
Rahman I
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):15-29. PubMed ID: 18046899
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants and mucolytics in COPD management: when (if ever) and in whom?
Hillas G; Nikolakopoulou S; Hussain S; Vassilakopoulos T
Curr Drug Targets; 2013 Feb; 14(2):225-34. PubMed ID: 23256719
[TBL] [Abstract][Full Text] [Related]
13. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
Domej W; Oettl K; Renner W
Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
Dailah HG
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
[TBL] [Abstract][Full Text] [Related]
16. COPD: balancing oxidants and antioxidants.
Fischer BM; Voynow JA; Ghio AJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD.
Shute JK; Puxeddu E; Calzetta L
Curr Opin Pharmacol; 2018 Jun; 40():39-45. PubMed ID: 29455115
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological antioxidant strategies as therapeutic interventions for COPD.
Rahman I
Biochim Biophys Acta; 2012 May; 1822(5):714-28. PubMed ID: 22101076
[TBL] [Abstract][Full Text] [Related]
19. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
Bernardo I; Bozinovski S; Vlahos R
Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
Wang XL; Li T; Li JH; Miao SY; Xiao XZ
Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
